Pfizer on Monday won a bid in a London court to invalidate two of GSK's patents relating to a respiratory syncytial virus ...

RSV hospitalizes thousands of people in the US every year. Three new vaccines could help stem the spread, but there are ...

Low uptake in the RSV and COVID vaccine markets is not surprising, an analyst says, and could mean weak earnings for ...

Dr. Jaunita Mora said the respiratory syncytial virus is the leading cause of infant hospitalizations. Here are the people ...

The recommendations, to administer both the shot and the antibody or either, come after the WHO's strategic advisory group on ...

In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...

Despite the Centers for Disease Control and Prevention's recommendations, vaccine rates against COVID-19, RSV, and the flu ...

Albertans can now book immunization appointments to protect against fall respiratory viruses. Appointments can be made ...

Infections caused by the latest variant have symptoms including fever, chills, fatigue, cough, congestion and headache.

If you, for some reason, don’t get the RSV vaccine while you’re pregnant, you can (and should!) still protect your baby after ...

Spread of the virus is seasonal, with activity often picking up in the fall after kids go back to school. Activity usually ...

Pfizer (NYSE:PFE) has reportedly succeeded in getting a U.K. court to invalidate two of GSK’s (NYSE:GSK) patents for its RSV ...